Finance

Beta
Lists
BIORQ:OTCMKTS
Biora Therapeutics Inc
$0.0030
+2,900.00%
(+0.0029) 1D
Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIORQ...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
6.78K
Avg. vol.
2.08K
Volume
236.00
52-wk high
$0.34
52-wk low
$0.00
Beta
1.23
Shares outstanding
4.52M
No. of employees
58
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
6.78K
Avg. vol.
2.08K
Volume
236.00
52-wk high
$0.34
52-wk low
$0.00
Beta
1.23
Shares outstanding
4.52M
No. of employees
58
News stories
From sources across the web
About Biora Therapeutics Inc
CEO-
Employees58
Founded2010
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitebioratherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Revenue
-
542.00K
318.00K
32.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
7.70M
5.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
8.40M
10.65M
Operating expense
-
-
16.10M
16.26M
Total operating expenses
-
-
16.10M
16.26M
Operating income
-
-
-15.79M
-16.23M
Other non operating income
-
-
22.90M
6.68M
EBT including unusual items
-
-
6.40M
-22.26M
EBT excluding unusual items
-
-
6.40M
-11.56M
Income tax expense
-
-
-67.00K
-44.00K
Effective tax rate
-
-
-1.05%
0.20%
Other operating expenses
-
-
-
-
Net income
-
-
6.46M
-18.40M
Net profit margin
-
-
2,033.02%
-57,506.25%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-711.00K
-2.02M
Net interest expenses
-
-
-711.00K
-2.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-15.68M
-16.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer